Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Seeman

Showing results (31-40 of 325) with videos related to

Pageof 33
Sort By:
Canadian Journal of Physiology and Pharmacology|March 1, 1982
Effects of antihypertensive clonidine congeners on alpha-adrenergic receptorsM Titeler, P Seeman
European Journal of Pharmacology|October 17, 1980
Presynaptically acting catecholamines bind to alpha 2-adrenoceptors labelled by 3H-clonidineM Titeler, P Seeman
Life Sciences|December 15, 1977
Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, alpha-noradrenergic and naloxone receptorsP Muller, P Seeman
Experientia|November 15, 1978
Antiparkinsonian drug doses and neuroleptic receptorsM Titeler, P Seeman
Biochimica Et Biophysica Acta|January 17, 1972
The membrane concentrations of neutral and positive anesthetics (alcohols, chlorpromazine, morphine) fit the Meyer-Overton rule of anesthesia; negative narcotics do notS Roth, P Seeman
Canadian Journal of Physiology and Pharmacology|June 1, 1974
The impulse-blocking concentrations of anesthetics, alcohols, anticonvulsants, barbiturates, and narcotics on phrenic and sciatic nervesA Staiman, P Seeman
European Journal of Pharmacology|June 15, 1979
Selective labelling of different dopamine receptors by a new agonist 3H-ligand: 3H-N-propylnorapomorphineM Titeler, P Seeman
Molecular Psychiatry|May 13, 1998
Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptorsP Seeman, T Tallerico
Advances in Neurology|January 1, 1987
Dopamine D2 receptor density in parkinsonian brain is constant for duration of disease, age, and duration of L-dopa therapyM Guttman, P Seeman
The American Journal of Psychiatry|June 9, 1999
Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapineP Seeman, T Tallerico
Pageof 33

Showing results (31-40 of 325) with videos related to

Sort By:
Pageof 33
Canadian Journal of Physiology and Pharmacology|March 1, 1982
Effects of antihypertensive clonidine congeners on alpha-adrenergic receptorsM Titeler, P Seeman
European Journal of Pharmacology|October 17, 1980
Presynaptically acting catecholamines bind to alpha 2-adrenoceptors labelled by 3H-clonidineM Titeler, P Seeman
Life Sciences|December 15, 1977
Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, alpha-noradrenergic and naloxone receptorsP Muller, P Seeman
Experientia|November 15, 1978
Antiparkinsonian drug doses and neuroleptic receptorsM Titeler, P Seeman
Biochimica Et Biophysica Acta|January 17, 1972
The membrane concentrations of neutral and positive anesthetics (alcohols, chlorpromazine, morphine) fit the Meyer-Overton rule of anesthesia; negative narcotics do notS Roth, P Seeman
Canadian Journal of Physiology and Pharmacology|June 1, 1974
The impulse-blocking concentrations of anesthetics, alcohols, anticonvulsants, barbiturates, and narcotics on phrenic and sciatic nervesA Staiman, P Seeman
European Journal of Pharmacology|June 15, 1979
Selective labelling of different dopamine receptors by a new agonist 3H-ligand: 3H-N-propylnorapomorphineM Titeler, P Seeman
Molecular Psychiatry|May 13, 1998
Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptorsP Seeman, T Tallerico
Advances in Neurology|January 1, 1987
Dopamine D2 receptor density in parkinsonian brain is constant for duration of disease, age, and duration of L-dopa therapyM Guttman, P Seeman
The American Journal of Psychiatry|June 9, 1999
Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapineP Seeman, T Tallerico
Pageof 33